Merck & Co Inc (MRK)
125.36
+0.30
(+0.24%)
USD |
NYSE |
Apr 17, 16:00
125.60
+0.24
(+0.19%)
After-Hours: 19:49
Merck Price to Book Value: 8.448 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 16, 2024 | 8.428 |
April 15, 2024 | 8.504 |
April 12, 2024 | 8.474 |
April 11, 2024 | 8.502 |
April 10, 2024 | 8.542 |
April 09, 2024 | 8.539 |
April 08, 2024 | 8.529 |
April 05, 2024 | 8.626 |
April 04, 2024 | 8.603 |
April 03, 2024 | 8.754 |
April 02, 2024 | 8.784 |
April 01, 2024 | 8.828 |
March 28, 2024 | 8.892 |
March 27, 2024 | 8.879 |
March 26, 2024 | 8.459 |
March 25, 2024 | 8.445 |
March 22, 2024 | 8.346 |
March 21, 2024 | 8.331 |
March 20, 2024 | 8.346 |
March 19, 2024 | 8.235 |
March 18, 2024 | 8.184 |
March 15, 2024 | 8.189 |
March 14, 2024 | 8.121 |
March 13, 2024 | 8.233 |
March 12, 2024 | 8.266 |
Date | Value |
---|---|
March 11, 2024 | 8.274 |
March 08, 2024 | 8.323 |
March 07, 2024 | 8.356 |
March 06, 2024 | 8.340 |
March 05, 2024 | 8.278 |
March 04, 2024 | 8.360 |
March 01, 2024 | 8.556 |
February 29, 2024 | 8.569 |
February 28, 2024 | 8.639 |
February 27, 2024 | 8.696 |
February 26, 2024 | 8.683 |
February 23, 2024 | 8.724 |
February 22, 2024 | 8.711 |
February 21, 2024 | 8.634 |
February 20, 2024 | 8.584 |
February 16, 2024 | 8.612 |
February 15, 2024 | 8.528 |
February 14, 2024 | 8.479 |
February 13, 2024 | 8.453 |
February 12, 2024 | 8.447 |
February 09, 2024 | 8.454 |
February 08, 2024 | 8.532 |
February 07, 2024 | 8.590 |
February 06, 2024 | 8.551 |
February 05, 2024 | 8.504 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.866
Minimum
Feb 24 2022
8.892
Maximum
Mar 28 2024
6.635
Average
6.698
Median
Dec 29 2023
Price to Book Value Benchmarks
Amgen Inc | 22.71 |
Johnson & Johnson | 5.061 |
Eli Lilly and Co | 66.26 |
Pfizer Inc | 1.612 |
Moderna Inc | 2.859 |
Price to Book Value Related Metrics
PE Ratio | 895.43 |
PS Ratio | 5.306 |
Price to Free Cash Flow | 34.88 |
Price | 125.36 |
Earnings Yield | 0.11% |
Market Cap | 317.49B |
Operating PE Ratio | 108.01 |
Normalized PE Ratio | 393.15 |